PTC Therapeutics (PTCT) PT Raised to $85 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $70.56 --0%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $85.00 (from $82.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- Morgan Stanley Downgrades Barclays Plc (BARC:LN) (BCS) to Equalweight
- Targa Resources (TRGP) PT Raised to $324 at Wells Fargo
- Credo Tech (CRDO) PT Lowered to $275 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
